Biomarker Clinical Trial
Official title:
Can we Improve Mortality Prediction in Patients With Sepsis in the Emergency Department
This study aims to identify the prognostic role of procalcitonin (PCT), soluble Triggering Receptor Expressed on Myeloid Cells-1 (sTREM-1), the soluble form of the urokinase plasminogen activator receptor (suPAR), highly sensitive C-reactive protein (hs-CRP), Interleukin-6 (IL-6), and azurocidin 1 (AZU1) in 28-day mortality for patients with sepsis in Emergency Department.
The levels of the specified biomarkers were measured upon patient arrival at the Emergency Department (ED) and analyzed their correlation with 28-day mortality. The values of these biomarkers were monitored over the initial three days following admission to the ED, aiming to explore their potential in guiding the de-escalation of antibiotic treatment. Considering their prognostic significance, the main goal is to develop a novel scoring system tailored for use in the emergency department setting. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT03219593 -
Apatinib as the First-Line Therapy in Elderly Locally Advanced or Metastatic Gastric Cancer
|
Phase 2 | |
Active, not recruiting |
NCT04681040 -
Risk Stratification of COVID-19 Using Urine Biomarkers
|
||
Recruiting |
NCT05372172 -
Tennessee Alzheimer's Project
|
||
Recruiting |
NCT06096766 -
the Correlation Between Ovarian Function and Serum Biomarkers
|
||
Completed |
NCT04103632 -
Screening and Diagnosing Exercise-induced Bronchoconstriction in Recreational Young Athletes (12-18 y)
|
N/A | |
Completed |
NCT01159730 -
Study to Assess the Safety and Efficacy of Multiple Doses of VB-201 on Biomarkers
|
Phase 2 | |
Completed |
NCT04507724 -
The Use of Biochemical Analyzes to Monitor the Development of Wounds
|
||
Active, not recruiting |
NCT05027165 -
Prospective Evaluation of Immunological, Molecular-genetic, Image-based and Microbial Analyzes to Characterize Tumor Response and Control in Patients With Inoperable Stage III NSCLC Treated With Chemoradiotherapy Followed by Consolidation Therapy With Durvalumab
|
||
Not yet recruiting |
NCT02931136 -
Early Diagnosis and Early Treatment of Alzheimer's Disease Based on Senile Plaque Imaging
|
Phase 4 | |
Not yet recruiting |
NCT03739892 -
Biomarkers to Predict Gain From Therapy in Motor Stroke
|
N/A | |
Recruiting |
NCT03801681 -
ARrhythmias in MYocarditis
|
||
Recruiting |
NCT05372965 -
The Effects of Smoking on miRNA-223 Before-After Non-Surgical Periodontal Therapy in Patients With Stage-3, Grade-B Periodontitis
|
N/A | |
Completed |
NCT04772495 -
miRNA Biomarkers in Multiple Sclerosis
|
||
Active, not recruiting |
NCT06178692 -
Validation Study of a Serum-miRNA Signature in Glioma Patients.
|
||
Recruiting |
NCT04931537 -
Screening and Application Research of Early Diabetic Nephropathy Markers Based on Lipidomics.
|
||
Recruiting |
NCT05090410 -
Efficacy and Safety of Selective JAK 1 Inhibitor Filgotinib in Active Rheumatoid Arthritis Patients With Inadequate Response to Methotrexate
|
Phase 3 | |
Not yet recruiting |
NCT05764356 -
Imapct of bioMarkers on Pharmacodynamics and Bleeding Risk of Direct Oral AntiCoagulants and Ticagrelor Study II
|
||
Recruiting |
NCT02201446 -
The Role of Circulating Soluble CD74 in Acute Lung Injury
|
N/A | |
Not yet recruiting |
NCT05752890 -
A Novel Biomarker for Response and Prognosis of HBV-related Hepatocellular Carcinoma
|
||
Completed |
NCT04786431 -
Shotgun Mass Spectrometry-based Lipid Profiling in Chronic Inflammatory Diseases
|